Literature DB >> 25892555

E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells.

Daniela S Castillo1, Anna Campalans, Laura M Belluscio, Abel L Carcagno, J Pablo Radicella, Eduardo T Cánepa, Nicolás Pregi.   

Abstract

E2F transcription factors regulate a wide range of biological processes, including the cellular response to DNA damage. In the present study, we examined whether E2F family members are transcriptionally induced following treatment with several genotoxic agents, and have a role on the cell DNA damage response. We show a novel mechanism, conserved among diverse species, in which E2F1 and E2F2, the latter specifically in neuronal cells, are transcriptionally induced after DNA damage. This upregulation leads to increased E2F1 and E2F2 protein levels as a consequence of de novo protein synthesis. Ectopic expression of these E2Fs in neuronal cells reduces the level of DNA damage following genotoxic treatment, while ablation of E2F1 and E2F2 leads to the accumulation of DNA lesions and increased apoptotic response. Cell viability and DNA repair capability in response to DNA damage induction are also reduced by the E2F1 and E2F2 deficiencies. Finally, E2F1 and E2F2 accumulate at sites of oxidative and UV-induced DNA damage, and interact with γH2AX DNA repair factor. As previously reported for E2F1, E2F2 promotes Rad51 foci formation, interacts with GCN5 acetyltransferase and induces histone acetylation following genotoxic insult. The results presented here unveil a new mechanism involving E2F1 and E2F2 in the maintenance of genomic stability in response to DNA damage in neuronal cells.

Entities:  

Keywords:  ASCAT, CAT antisense; ASE2F1, E2F1 antisense; ASE2F2, E2F2 antisense; DNA damage response; DNA repair; E2F transcription factor; NCS, neocarzinostatin; ODN, oligodeoxynucleotide; genomic stability; mut E2F DO, mutant E2F decoy oligodeoxynucleotide; neuronal cells; wt E2F DO, wild-type E2F decoy oligodeoxynucleotide

Mesh:

Substances:

Year:  2015        PMID: 25892555      PMCID: PMC4614399          DOI: 10.4161/15384101.2014.985031

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  67 in total

1.  E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.

Authors:  J W Zhu; S J Field; L Gore; M Thompson; H Yang; Y Fujiwara; R D Cardiff; M Greenberg; S H Orkin; J DeGregori
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Differential regulation of E2F1 apoptotic target genes in response to DNA damage.

Authors:  Natalia Pediconi; Alessandra Ianari; Antonio Costanzo; Laura Belloni; Rita Gallo; Letizia Cimino; Antonio Porcellini; Isabella Screpanti; Clara Balsano; Edoardo Alesse; Alberto Gulino; Massimo Levrero
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

3.  Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.

Authors:  Kenichi Yoshida; Ituro Inoue
Journal:  Oncogene       Date:  2004-08-19       Impact factor: 9.867

4.  The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells.

Authors:  Ariel Quiñones; Karl U Dobberstein; Nikolai G Rainov
Journal:  Life Sci       Date:  2003-05-16       Impact factor: 5.037

5.  Regulation of E2F1 activity by acetylation.

Authors:  M A Martínez-Balbás; U M Bauer; S J Nielsen; A Brehm; T Kouzarides
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

6.  Transcriptional regulation of 5-aminolevulinate synthase by phenobarbital and cAMP-dependent protein kinase.

Authors:  C L Varone; L E Giono; A Ochoa; M M Zakin; E T Cánepa
Journal:  Arch Biochem Biophys       Date:  1999-12-15       Impact factor: 4.013

7.  Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.

Authors:  Norbert M Wikonkal; Eva Remenyik; Dejan Knezevic; Wengeng Zhang; Ming Liu; Hongyu Zhao; T R Berton; David G Johnson; Douglas E Brash
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

8.  Regulation of E2F1 by BRCT domain-containing protein TopBP1.

Authors:  Kang Liu; Fang-Tsyr Lin; J Michael Ruppert; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

9.  Chk2 activates E2F-1 in response to DNA damage.

Authors:  Craig Stevens; Linda Smith; Nicholas B La Thangue
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

10.  Distinct spatiotemporal patterns and PARP dependence of XRCC1 recruitment to single-strand break and base excision repair.

Authors:  Anna Campalans; Thierry Kortulewski; Rachel Amouroux; Hervé Menoni; Wim Vermeulen; J Pablo Radicella
Journal:  Nucleic Acids Res       Date:  2013-01-25       Impact factor: 16.971

View more
  17 in total

1.  Model scenarios for cell cycle re-entry in Alzheimer's disease.

Authors:  Nishtha Pandey; P K Vinod
Journal:  iScience       Date:  2022-06-07

2.  E2F1 Expression and Apoptosis Initiation in Crayfish and Rat Peripheral Neurons and Glial Cells after Axonal Injury.

Authors:  Valentina Dzreyan; Moez Eid; Stanislav Rodkin; Maria Pitinova; Svetlana Demyanenko
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

3.  Transcriptional targets of senataxin and E2 promoter binding factors are associated with neuro-degenerative pathways during increased autophagic flux.

Authors:  Aaron E Casey; Wenjun Liu; Leanne K Hein; Timothy J Sargeant; Stephen M Pederson; Ville-Petteri Mäkinen
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

4.  FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma.

Authors:  Yu Wang; Guangchao Wang; Yunping Ma; Jinglei Teng; Yan Wang; Yongping Cui; Yan Dong; Shujuan Shao; Qimin Zhan; Xuefeng Liu
Journal:  Chin J Cancer Res       Date:  2019-08       Impact factor: 5.087

5.  Comparison of gene expression response to neutron and x-ray irradiation using mouse blood.

Authors:  Constantinos G Broustas; Yanping Xu; Andrew D Harken; Guy Garty; Sally A Amundson
Journal:  BMC Genomics       Date:  2017-01-03       Impact factor: 3.969

6.  The Role of Crosstalk between AR3 and E2F1 in Drug Resistance in Prostate Cancer Cells.

Authors:  Jin Xu; Xi Yang; Dhanraj Deshmukh; Hegang Chen; Shengyun Fang; Yun Qiu
Journal:  Cells       Date:  2020-04-28       Impact factor: 6.600

7.  Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways.

Authors:  Xiangqi Meng; Yu Zhao; Bo Han; Caijun Zha; Yangong Zhang; Ziwei Li; Pengfei Wu; Tengfei Qi; Chuanlu Jiang; Yang Liu; Jinquan Cai
Journal:  Nat Commun       Date:  2020-01-30       Impact factor: 14.919

8.  Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines.

Authors:  Hong-Chieh Tsai; Kuo-Chen Wei; Pin-Yuan Chen; Chiung-Yin Huang; Ko-Ting Chen; Ya-Jui Lin; Hsiao-Wei Cheng; Chun-Hao Huang; Hsiang-Tsui Wang
Journal:  Neuromolecular Med       Date:  2021-06-01       Impact factor: 3.843

9.  Optimization of recombinant Zika virus NS1 protein secretion from HEK293 cells.

Authors:  Julieta S Roldán; Alejandro Cassola; Daniela S Castillo
Journal:  Biotechnol Rep (Amst)       Date:  2020-02-11

10.  Defined factors to reactivate cell cycle activity in adult mouse cardiomyocytes.

Authors:  Justin Judd; Jonathan Lovas; Guo N Huang
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.